Study Designs for INTerpath-002 and INTerpath-009 of Adjuvant Intismeran Autogene Plus Pembrolizumab for Non-Small Cell Lung Cancer. // Annals of Thoracic Surgery Short Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2772993126001245?dgcid=rss_sd_all
Study Designs for INTerpath-002 and INTerpath-009 of Adjuvant Intismeran Autogene Plus Pembrolizumab for Non-Small Cell Lung Cancer. Annals of Thoracic Surgery Short Reports. https://www.sciencedirect.com/science/article/pii/S2772993126001245?dgcid=rss_sd_all
“Study Designs for INTerpath-002 and INTerpath-009 of Adjuvant Intismeran Autogene Plus Pembrolizumab for Non-Small Cell Lung Cancer.” Annals of Thoracic Surgery Short Reports.
@article{article106778,
title = {Study Designs for INTerpath-002 and INTerpath-009 of Adjuvant Intismeran Autogene Plus Pembrolizumab for Non-Small Cell Lung Cancer},
journal = {Annals of Thoracic Surgery Short Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2772993126001245?dgcid=rss_sd_all}
}